Advertisement

Treatment of Unresectable Esophageal Cancer: Indications and Long-term Results

  • Michele Pavarana
  • Teodoro Sava
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

There is considerable debate in the literature on the appropriate preoperative treatment of esophageal squamous cell carcinoma (ESCC), with valid options being chemotherapy (CT), chemoradiotherapy (CRT), followed or not by surgery. Some authors are of the opinion that in patients with good clinical response, surgery can improve local control and minimize, in case of relapse, the need for palliative stenting; however, surgery does not seem to improve overall survival. Late surgical morbidity and mortality, even in high-volume centers, is still considerable. For this reason, definitive CRT has been proposed for patients with advanced ESCC (cT3-cT4), restricting surgery to non-responding patients (salvage surgery) [1, 2, 3, 4, 5].

Keywords

Esophageal Cancer Esophageal Squamous Cell Carcinoma Salvage Surgery Good Clinical Response Nonresponding Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Ishihara R, Yamamoto S, Iishi H et al (2010) Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 76:123–129PubMedCrossRefGoogle Scholar
  2. 2.
    Minsky BD, Pajak TF, Ginsberg RJ et al (2002) INT0123 phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167–174PubMedCrossRefGoogle Scholar
  3. 3.
    Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long term follow-up of a prospective randomized trial. JAMA 281:1623–1627PubMedCrossRefGoogle Scholar
  4. 4.
    Ishikura S, Nihei K, Ohtsu A et al (2003) Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697–2702PubMedCrossRefGoogle Scholar
  5. 5.
    Tahara M, Ohtsu A, Hironaka S et al (2005) Clinical impact of criteria for complete response of primary site to treatment of esophageal cancer. Jpn J Clin Oncol 35:316–323PubMedCrossRefGoogle Scholar
  6. 6.
    Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75:348–356PubMedCrossRefGoogle Scholar
  7. 7.
    Swisher SG, Wynn P, Putnam JB et al (2002) Salvage esophagectomy for recurrent tumours after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123:175–183PubMedCrossRefGoogle Scholar
  8. 8.
    Gardner-Thorpe J, Hardwick RH, Dwerryhouse SJ (2007) Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br J Surg 94:1059–1066PubMedCrossRefGoogle Scholar
  9. 9.
    Stahl M, Walz MK, Stuschke M et al (2007) Preoperative chemotherapy versus preoperative chemoradiotherapy in locally advanced esophagogastric adenocarcinomas: first results of a randomized phase III trial. Proc Am Soc Clin Oncol 25:4511Google Scholar
  10. 10.
    Urba SG, Orringer MB, Turrisi A et al (2007) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313Google Scholar
  11. 11.
    Bosset JF, Gignoux M, Tribouled JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167PubMedCrossRefGoogle Scholar
  12. 12.
    Ohtsu A, Boku N, Muro K et al (1999) Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915–2921PubMedGoogle Scholar
  13. 13.
    Ishida K, Iizuka T, Ando N et al (1996) Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus. Jpn J Clin Oncol 26:310–315PubMedCrossRefGoogle Scholar
  14. 14.
    Burmeister BH, Denham JW, O’Brien M et al (1995) Combined modality therapy for esophageal carcinoma: preliminary results from a large Austrialasian multicenter study. Int J Radiat Oncol Biol Phys 32:997–1006PubMedCrossRefGoogle Scholar
  15. 15.
    Blanke CD, Choy H, Leach SD (1997) Combined modality therapy for esophageal cancer. Semin Radiat Oncol 7:15–23CrossRefGoogle Scholar
  16. 16.
    Rizk NP, Venkatraman E, Bains MS et al (2007) American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. J Clin Oncol 25:507–512PubMedCrossRefGoogle Scholar
  17. 17.
    Nishimura Y, Suzuki M, Nakamatsu K et al (2002) Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 53:134–139PubMedCrossRefGoogle Scholar
  18. 18.
    Herskovic A, Martz K, al-Sarraf M et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the eophagus. N Engl J Med 326:1593–1598PubMedCrossRefGoogle Scholar
  19. 19.
    al-Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284PubMedGoogle Scholar
  20. 20.
    Smith TJ, Ryan LM, Douglass HO Jr et al (1998) Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42:269–276PubMedCrossRefGoogle Scholar
  21. 21.
    Bidoli P, Bajetta E, Stani SC et al (2002) Ten-year survival with chemotherapy and radiotherapy in patients with suamous cell carcinoma of the esophagus. Cancer 94:352–361PubMedCrossRefGoogle Scholar
  22. 22.
    Bedenne L, Michel P, Bouche O et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168PubMedCrossRefGoogle Scholar
  23. 23.
    Stahl M, Stuschke M, Lehmann N et al (2005) Chemoradiation with or without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317PubMedCrossRefGoogle Scholar
  24. 24.
    Wakui R, Yamashita H, Okuma K et al (2010) Esophageal cancer: definitive chemioradiotherapy for elderly patients. Dis Esophagus 23:572–579PubMedCrossRefGoogle Scholar
  25. 25.
    Hurmuzlu M, Monge OR, Smaaland R et al (2010) High-dose definitive concomitant chemioradiotherapy in non-metastatic locallyadvanced esophageal cancer: toxicity and outcome. Dis Esophagus 23:244–252PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Michele Pavarana
    • 1
  • Teodoro Sava
  1. 1.Oncology UnitBorgo Trento HospitalVeronaItaly

Personalised recommendations